Latest current cash for COYA: $43B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Coya Therapeutics (COYA) currently reports a current cash of $43B as of June 2026. That compares with $30B in the prior-year period — up 45.1% year over year. Use the charts on this page to explore Coya Therapeutics's current cash history and peer comparisons.
Coya Therapeutics's current cash increased from $30B to $43B — a 45.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Coya Therapeutics reported $43B in current cash as of June 2026. That compares with $30B in the prior-year period — up 45.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $43B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Coya Therapeutics, and consider following COYA for alerts when major investors trade the stock.